Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. The promise of AI in clinical trials is enormous: faster drug development ...
The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce ...
OAKLAND, Calif. (AP) — At the heart of the trial pitting Elon Musk against OpenAI CEO Sam Altman is a moment when they found ...
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.” ...
Please provide your email address to receive an email when new articles are posted on . In our journey through academia, contract research organizations, big pharma and biotech startups, we have had ...
Artificial intelligence is rapidly modernizing clinical trial design, recruitment, and data management, cutting startup times, reducing errors, and improving patient engagement. New tools use machine ...
Plus: The Pentagon has struck sweeping AI deals for classified work. This is today's edition of The Download, our weekday ...
The Musk v. Altman trial tests whether OpenAI’s for‑profit shift was legal — a ruling that could reshape how AI labs raise ...
Researchers based at Harvard Medical School and Beth Israel Deaconess Medical Center found that an AI reasoning model, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results